0531962 - ÚMG 2021 RIV US eng J - Journal Article
Přibyl, Miroslav - Hubáčková, Soňa - Moudrá, Alena - Vančurová, Markéta - Polackova, H. - Stopka, T. - Jonasova, A. - Bokorova, R. - Fuchs, O. - Stříteský, J. - Šalovská, Barbora - Bártek, Jiří - Hodný, Zdeněk
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.
Molecular Oncology. Roč. 14, č. 10 (2020), s. 2403-2419. ISSN 1574-7891. E-ISSN 1878-0261
R&D Projects: GA ČR(CZ) GA17-07635S; GA MŠMT(CZ) ED1.1.00/02.0109
Institutional support: RVO:68378050
Keywords : 5-azacytidine * biomarker * mds * MDSCs * suprabasin
OECD category: Hematology
Impact factor: 6.603, year: 2020
Method of publishing: Open access
https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12768
Permanent Link: http://hdl.handle.net/11104/0310586
Přibyl, Miroslav - Hubáčková, Soňa - Moudrá, Alena - Vančurová, Markéta - Polackova, H. - Stopka, T. - Jonasova, A. - Bokorova, R. - Fuchs, O. - Stříteský, J. - Šalovská, Barbora - Bártek, Jiří - Hodný, Zdeněk
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.
Molecular Oncology. Roč. 14, č. 10 (2020), s. 2403-2419. ISSN 1574-7891. E-ISSN 1878-0261
R&D Projects: GA ČR(CZ) GA17-07635S; GA MŠMT(CZ) ED1.1.00/02.0109
Institutional support: RVO:68378050
Keywords : 5-azacytidine * biomarker * mds * MDSCs * suprabasin
OECD category: Hematology
Impact factor: 6.603, year: 2020
Method of publishing: Open access
https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12768
Permanent Link: http://hdl.handle.net/11104/0310586